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AnkyrinNa-K-ATPase located on the basolateral membrane (BLM) of intestinal epithelial cells provides a favorable intra-
cellular Na+ gradient to promote all Na dependent co-transport processes across the brush border membrane
(BBM). Down-regulation of Na-K-ATPase activity has been postulated to alter the absorption via Na-solute co-
transporters in human inﬂammatory bowel disease (IBD). Further, the altered activity of a variety of Na-solute
co-transporters in intact villus cells has been reported in animal models of chronic enteritis. But the molecular
mechanismof down-regulation ofNa-K-ATPase is not known. In thepresent study, using a rabbitmodel of chron-
ic intestinal inﬂammation, which resembles human IBD, Na-K-ATPase in villus cells was shown to decrease. The
relativemRNA abundance of α-1 and β-1 subunits was not altered in villus cells during chronic intestinal inﬂam-
mation. Similarly, the protein levels of these subunits were also not altered in villus cells during chronic enteritis.
However, the BLM concentration of α-1 and β-1 subunits was diminished in the chronically inﬂamed intestinal
villus cells. An ankyrin–spectrin skeleton is necessary for the proper trafﬁcking of Na-K-ATPase to the BLM of the
cell. In the present study, ankyrin expression was markedly diminished in villus cells from the chronically in-
ﬂamed intestine resulting in depolarization of ankyrin-G protein. The decrease of Na-K-ATPase activity was com-
parable to that seen in ankyrin knockdown IEC-18 cells. Therefore, altered localization of Na-K-ATPase as a result
of transcriptional down-regulation of ankyrin-G mediates the down-regulation of Na-K-ATPase activity during
chronic intestinal inﬂammation.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Na-K-ATPase is an integral protein present in the BLMofmammalian
epithelial cells. It is composed of α and β subunits, where the α-1
subunit is essential for the functioning of Na-K-ATPase while the β-1
subunit is important for stabilizing the correct folding of the α-1
polypeptide. The ankyrin–spectrin skeleton is necessary for the
proper trafﬁcking of Na-K-ATPase to the BLM of the cell. Thus, alter-
ation at any one of these critical steps can affect the functioning of
Na-K-ATPase.
Na-K-ATPase is responsible for establishing andmaintaininghigh in-
tracellular K+ and low intracellular Na+ concentrations that result in ave, Joan C. Edwards School of
, USA. Tel.: +1 304 691 1841;
m).
e, Kolkata 700 026, India.
, Biochemistry & Microbiology,
ginia University, Morgantown,favorable intracellular Na+ gradient [1]. In theory, the nutrient-coupled
uptake of Na+ entry across the BBM increases [Na+]i, which, in turn,
increases Na+ extrusion across the BLM through Na-K-ATPase. This fa-
vorable transcellular Na+ gradient is efﬁciently maintained by BLM
Na-K-ATPase and is in turn essential for the proper functioning of BBM
Na-coupled nutrient co-transporters, which are the primary means of
absorption of many (macro) nutrients (e.g. glucose, amino acid), some
vitamins and certain nucleic acids (e.g. adenosine). Thus, the
proper functioning of Na-K-ATPase is essential for efﬁcient nutrient
absorption and subsequent maintenance of good health. For this
reason, Na-K-ATPase has been found to play a signiﬁcant part in
the management and treatment of disease conditions such as diar-
rheal diseases. For example in diarrhea, though a signiﬁcant malab-
sorption of nutrients is seen, Na-K-ATPase function is preserved
thus forming the basis for oral rehydration therapy where the func-
tional Na-K-ATPase efﬁciently moves the Na+ salt and glucose in
the oral rehydration ﬂuid through the intestinal epithelial cells
along with water molecules resulting in the rehydration of the pa-
tients [2,3]. Also, in the chronically inﬂamed small intestine (e.g.
IBD and Crohn's disease), the cellular alteration of a variety of
BBM Na-solute co-transport processes is at least partially, a result
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villus cells [4–7]. For example, villus BBM Na-glutamine co-
transporter B0AT1 is down-regulated during inﬂammation partial-
ly due to the down-regulation of BLM Na-K-ATPase leading to the
loss of the intracellular Na+ gradient [7]. However, when Na-K-
ATPase activity was restored by treatment with a corticosteroid,
the BBM B0AT1 was also restored in villus cells, thus establishing
that Na-K-ATPase is, at least in part, responsible for the loss of a
BBM Na-nutrient co-transporter [8]. Finally, Na-K-ATPase is also
important for the osmotic balance and volume regulation of cells
[9].
Na-K-ATPase is a transmembrane heterodimer consisting of two
dissimilar subunits, α and β, present in equimolar amounts. The α sub-
unit regulates catalytic activity and contains intracellular binding sites
for ATP and Na+, a phosphorylation site and extracellular binding sites
for K+ [10]. The glycosylated β subunit is essential for Na-K-ATPase
function as it facilitates α/β heterodimer formation and subsequent
transport of the holoenzyme to the plasma membrane [11]. Multiple
isoforms of Na-K-ATPase α (α-1, α-2, α-3 and α-4) and β (β-1, β-2
and β-3) subunits are expressed in a developmental and tissue-
speciﬁc pattern [12–17]. Subunits α-1 and β-1, are constitutively
expressed in the majority of tissues, whereas the α-2, α-3 and α-4
genes, as well as the β-2 and β-3 genes, have limited expression [18].
A third small polypeptide, the γ subunit, is found in association with α
and β dimer in a tissue-speciﬁc manner and does not seem to be re-
quired for functional Na-K-ATPase and may play a regulatory role [19].
The cytoplasmic domain of the α subunit interacts with the
N-terminal domain of ankyrin [20], a protein that connects the Na-K-
ATPase to the spectrin (fodrin) basedmembrane skeleton and stabilizes
Na-K-ATPase at the plasma membrane [21].
Multiple mechanisms can possibly regulate the activity of Na-K-
ATPase subject to either physiological or pathophysiological conditions.
A dysfunction or deﬁciency of Na-K-ATPase has been identiﬁed in
chronic neurodegenerative disorder, and cardiovascular and renal
diseases [22–25]. Several studies have described a decreased activity
of Na-K-ATPase in acute and transient infectious enteritis [26–30]. In
chronic diarrheal diseases characterized by chronic intestinal inﬂamma-
tion resulting inmalabsorption and thusmalnutrition, alterations in Na-
K-ATPase function maybe even more important. For example, in an an-
imalmodel resembling IBD, it has been shown that Na-glucose (SGLT1),
Na-alanine (ATB0), Na-glutamine (B0AT1), Na-taurocholate (ASBT),
and Na-adenosine (DMT1) co-transport is diminished in intact villus
cells. In these instances described there is also a decrease in BLM
Na-K-ATPase [4–7]. Thus, it has been suggested that the decrease of
Na and nutrient absorption in diarrheal diseases characterized by
chronic intestinal inﬂammation is, at least in part, due to a down-
regulation of Na-K-ATPase in the BLM of villus cells. However, the
mechanism of the alteration of Na-K-ATPase during chronic intestinal
inﬂammation is not known. Therefore, in this study, the mechanism of
Na-K-ATPase down-regulation in villus cells from the chronically
inﬂamed intestine was determined.
2. Methods
2.1. Induction of chronic inﬂammation
New Zealand white rabbits (10–12 week old males; 2.0–2.2 kg)
were intragastrically inoculated with approximately 10,000 Eimeria
magna oocytes. The animals gradually developed chronic intestinal in-
ﬂammation with the peak being on days 13 and 14 post inoculation
when they showed symptoms of watery diarrhea. The animals
were euthanized on day 14 with an overdose of pentobarbital sodi-
um and the intestinal cells were isolated from the ileum immediately
after euthanization. Intestinal inﬂammation was conﬁrmed in the
rabbits through histological characteristics like villus blunting,
crypt hyperplasia and fusion, as well as immune cell (lymphocytes,plasma cells, neutrophils) inﬁltration of the mucosa by H&E staining.
Usually, 80–90% of the inoculated rabbits develop intestinal inﬂam-
mation and in the present study all the animals that were inoculated
with the oocytes successfully developed intestinal inﬂammation.
Control rabbits were sham inoculated with saline and did not show
any signs of intestinal inﬂammation as conﬁrmed through histologi-
cal examination. All the animal handling and maintenance were
done according to Institutional Animal Care and Use Committee
regulations.
2.2. Villus cell isolation
Villus cells were isolated from normal and chronically inﬂamed
rabbit small intestine by a Ca++ chelation technique as previously
described [29]. Brieﬂy, a 3-ft section of ileumwas ﬁlled with buffer con-
taining 0.15mMEDTA, 112mMNaCl, 25mMNaHCO3, 2.4 mMK2HPO4,
0.4 mM KH2PO4, 2.5 mM L-glutamine, 0.5 mM β-hydroxybutyrate, and
0.5 mM dithiothreitol, and gassed with 95% O2 and 5% CO2, pH 7.4, at
37 °C. The intestine was incubated in this solution for 3 min and gently
palpitated for another 3 min to facilitate cell dispersion. The ﬂuid was
then drained from the ileal loop, phenylmethylsulfonyl ﬂuoride was
added, and the suspension was centrifuged at 1000 g for 3 min. Villus
cells from fraction 2 were used for total RNA isolation, BLM, BBM and
cell extract preparations and immunocytochemistry.
2.3. RTQ-PCR studies
Total RNAwas isolated from normal and chronically inﬂamed rabbit
intestinal villus cells by using an RNeasy Plus total RNA puriﬁcationmini
kit obtained from Qiagen. Real-time quantitative PCR (RTQ-PCR) was
performed using total RNA isolated by a two-step method. First-strand
cDNA synthesis from total RNA was performed by using SuperScript III
from Invitrogen Life Technologies using an equal mixture of oligo (dT)
primer and random hexamers. The cDNA generated was used as a tem-
plate for real-time PCR using a TaqMan Universal PCR master mix from
Applied Biosystems (Foster City, CA) according to the manufacturer's
protocol. Table 1 describes rabbit Na-K-ATPase α-1, Na-K-ATPase β-1,
ankyrin and spectrin speciﬁc primer and probe sequences that were
used for the RTQ-PCR studies. Rabbit speciﬁcβ-actin primers and probes
were run along with all the RTQ-PCR as internal control. The expression
of β-actin was used to normalize the expression levels between the
individual samples. The sequences of the rabbit β-actin primers and
probes are also listed in Table 1. All experiments were performed in
triplicates.
2.4. Western blot studies
Western blotting for Na-K-ATPase α-1, Na-K-ATPase β-1, ankyrin-G
and spectrin was performed according to the standard protocols. BLM
protein and cell extracts were prepared from rabbit normal and
chronically inﬂamed ileal villus cells. BLM were prepared by the
sucrose-density gradient and differential centrifugation method, as
described previously [31]. BBM from rabbit intestinal villus cells were
prepared by CaCl2 precipitation and differential centrifugation as previ-
ously described [29]. The ﬁnal pellet of themembranewas resuspended
in RIPA buffer (50 mM Tris–HCl pH 7.4, 1% Igepal, 150 mM NaCl, 1 mM
EDTA, 1mMPMSF, 1mMNa3VO4, and 1mMNaF) containing a protease
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Cell extracts were pre-
pared by sonication after incubating the cells in RIPA for 30 min at 4 °C.
An equal volume of 2× SDS/sample buffer (100 mM Tris, 25% glycerol,
2% SDS, 0.01% bromophenol blue, 10% 2-ME, pH 6.8) was added and
the proteins were separated on a 9% polyacrylamide gel. The separated
proteins were transferred onto a polyvinylidene diﬂuoride membrane
and individually probed with the monoclonal primary antibodies,
mouse anti-Na-K-ATPase α-1 and mouse anti-Na-K-ATPase β-1
(Upstate Cell Signaling Solutions, Lake Placid, NY). For the expression
Table 1
List of primers and probes for Na-K-ATPase-α-1, β-1, ankyrin-G, spectrin and β-actin RTQ-PCR.
Na-K-α1 Forward primer 5′-TCTCCTACTGCCCTGGAA-3′
Reverse primer 5′-GAGTAGGGGAAGGCACAGAA-3′
TaqMan probe 5′-FAM-CCCTTAGGATGTATCCCCTCAAGCCT-TAMRA-3′
Na-K-β1 Forward primer 5′-ATGTGCTGCCGGTTCAGT-3′
Reverse primer 5′-ACCAGCGTAATCACCCATTC-3′
TaqMan probe 5′-FAM-AGATGAAGATAAGGAAGTTGGAAGCATGG-TAMRA-3′
Ankyrin Forward primer 5′-TGTGCCAGAAAAACACGATG-3′
Reverse primer 5′-GACTCCTCGGCAGTAGAGTTC-3′
TaqMan probe 5′-FAM-CCAGAGGAACAGGGTCAGCAAGAAGA-TAMRA-3′
Spectrin Forward primer 5′-CATGCAGCACAACCTGGA-3′
Reverse primer 5′-GAATTCTTTGAGGGCCTCCT-3′
TaqMan probe 5′-FAM-CAGATCCAGACCAGGAACACAACGG-TAMRA-3′
β-Actin Forward primer 5′-GCTATTTGGCGCTGGACTT-3′
Reverse primer 5′-GCGGCTCGTAGCTCTTCTC-3′
TaqMan probe 5′-FAM-AAGAGATGGCCACGGCGCGAAC-TAMRA-3′
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anti-ankyrin-G and rabbit anti-spectrin antibodies (Santa Cruz Biotech-
nology, CL). Secondary antibodies coupled to horseradish peroxidase
were used tomonitor the binding of the primary antibody. ECLWestern
blotting detection reagent (GE Healthcare Bio-Sciences, Piscataway, NJ)
was used to detect the speciﬁc protein signal. Ezrin (81 kDa) was used
as a loading control and all the experiments were performed in
triplicate.
2.5. Immunocytochemistry
Immunolocalization of Na-K-ATPase α-1, Na-K-ATPase β-1 and
ankyrin-G protein was determined by confocal immunoﬂuorescence
microscopy. Villus cells from normal and chronically inﬂamed rabbit in-
testine were ﬁxed on a poly-L-lysine coated coverslip in 4% paraformal-
dehyde (Electron Microscopy Science, PA) and permeabilized by
dipping cells for 10 s in chilled (−20 °C) 100% methanol. Nonspeciﬁc
binding sites were blocked by 20 minute incubation with 10% goat
serum at room temperature. The cells were then incubated overnight
withmouse anti-Na-K-ATPaseα-1 (Upsate, Lake Placid, NY) in 1:500 di-
lution and mouse anti-Na-K-ATPase β-1 (Upsate, Lake Placid, NY) in
1:200 dilution and rabbit anti-ankyrin-G primary antibody (Santa
Cruz Biotechnology, CL) in 1:500 dilution at 4 °C. Excess antibody was
removed by washing with PBS and incubated with Alexa Fluor® 647
goat anti-mouse IgG (H + L, Molecular Probes, Inc.) for α-1 and β-1
and Alexa Fluor® 488 goat anti-rabbit IgG (H + L, Molecular Probes,
Inc.) for ankyrin-G at room temperature for 1 h in 1:500 dilution. Excess
secondary antibody was removed by washing with PBS and the cover-
slips were mounted by ProLong Gold Antifade Reagent (Invitrogen Life
Technologies). Speciﬁc ﬁlters were applied to visualize the signals gen-
erated by the probes under a Zeiss LSM510 confocal microscope
(647 nm for Alexa Fluor® 488 and 519 nm for Alexa Fluor® 488), and
the appropriate visuals generated by the two probes were captured
individually. Visuals generated from each individual probe were also
superimposed for further data analysis.
2.6. Co-immunoprecipitation (co-IP)
Villus cells were lysed for 20 min at 4 °C in 2 ml of immunoprecipi-
tation (IP) buffer [10 mM Tris–HCl, 150 mM NaCl, 5 mM EDTA, 1 mM
EGTA, 0.5% deoxycholate, 1% Nonidet P-40, and 1× Complete protease
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO)]. The lysates were
centrifuged for 1 min at 10,000 g and the protein concentrations of
the supernatant were estimated with a Bio-Rad protein assay kit (Her-
cules, CA) using BSA as standard. An equal amount of protein (500 μg)
from normal and chronically inﬂamed intestinal villus cell lysates were
pre-cleared by incubation with 25 μl of pre-immune serum and 100 μl
of 50% Immobilized proteinG slurry (Pierce, IL) at 4 °C for 1 hwith gentle
shaking. The cleared supernatant was incubated with 20 μl of themonoclonal Na-K-ATPase α-1 antibody (Upsate, Lake Placid, NY), over-
night at 4 °C and an additional hour with 100 μl of a 50% Immobilized
protein G slurry at room temperature with gentle shaking. The
immunoadsorbants were centrifuged for 1 min at 10,000 g, washed
three times with IP buffer prior to the addition of 50 μl of Laemmli sam-
ple buffer (62.5 mM Tris–HCl, pH 6.8, 20% glycerol, 2% SDS, 5% β-
mercaptoethanol, and 0.01% bromophenol blue) and incubation in
room temperature for an hour. The immunoprecipitated proteins were
then resolved by SDS-PAGE followed by Western blot analysis to detect
the levels of Na-K-ATPase α-1 and its interacting ankyrin protein.
2.7. Cell culture
The normal, diploid, rat small intestinal IEC-18 cell line from
American Type Culture Collection (ATCC) was maintained in culture as
described earlier [32]. In brief, the cells between passage numbers 12
and 24, were maintained in DMEM (with 4.5 g/l glucose and 3.7 g/l Na
bicarbonate) containing 2 mM L-glutamine, 10% (vol/vol) bovine fetal
serum, 0.2 U/ml insulin, 0.5 mM β-hydroxybutyric acid, 100 U/ml pen-
icillin and 100 μg/ml streptomycin in a humidiﬁed atmosphere of 10%
CO2 at 37 °C. The cells were fed with fresh medium every 2 to 3 days.
At around 90% conﬂuence, the cells were passaged by trypsinization
with 0.1% trypsin/0.04% EDTA in phosphate buffered saline.
2.8. RNA interference
Silencer® pre-designed rat ankyrin speciﬁc siRNA (siRNA ID
s168097) and negative control (Cat. no. 4611) were obtained from
Ambion. 1.5 μg ankyrin or negative control siRNAs resuspended in
nucleofector solution, pH 7.4, containing 7.1 mM ATP, 11.6 mM
MgCl2·6H2O, 13.6 mM NaHCO3, 84 mM KH2PO4 and 2.1 mM glucose
were individually nucleofected into IEC-18 cells using a Nucleofector II
device (Amaxa Inc.) according to the manufacturer recommended
protocol. The cells grown for 3 days after electroporation were used
for Na-K-ATPase activity and Western blot analyses.
2.9. Na-K-ATPase assay
Na-K-ATPase activity was measured in cellular homogenates as the
amount of inorganic phosphate (Pi) liberated using a calorimetric
method by Forbush [33]with fewmodiﬁcations. Brieﬂy, 20 μg of cellular
homogenatewas added to anassaymedium containing 50mMTris–HCl
(pH 7.2), 5 mMMgCl2 with 20mMKCl and 100mMNaCl, with or with-
out 1 mMOuabain. The enzyme activity was initiated by the addition of
20 mM ATP–Tris to the assay mixture with the cellular homogenate
followed by incubated at 37 °C for 15 min. The assay reaction was
stopped at 15 min by the addition of a 1 ml ice cold mixture of 2.8%
ascorbic acid, 0.48% ammonium molybdate, and 2.8% sodium dodecyl
sulfate (SDS)–0.48 M HCl solution followed by incubation in ice for
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after the addition of 1.5 ml of a solution containing 2% each of sodium
citrate, sodium arsenate and acetic acid. Readings were obtained at
705 nm in a UV spectrophotometer (Shimadzu UV-1601). Na-K-
ATPase activity was determined as the difference between the Pi
released from assays of identical samples with and without Ouabain.
Enzyme speciﬁc activity was ﬁnally expressed as nanomoles of Pi re-
leased per milligram protein per minute.
2.10. Data presentation
Where data were averaged, means ± SE are shown, except when
error bars are inclusive within the symbol. The number (n) for any set
of experiments refers to the number of rabbits. Student's t-test was
used for statistical analysis.
3. Results
3.1. Na-K-ATPase activity
Na-K-ATPase activity was measured in homogenates of villus
cells isolated from rabbit normal and chronically inﬂamed smallFig. 1. Na-K-ATPase α-1 and β-1 subunit proteins and mRNA expression in villus cells during
experiments. Na-K-ATPase α-1 protein was markedly diminished in villus cell basolatera
(B) Representative Na-K-ATPase β-1 Western blot from 3 independent experiments. Na-K-AT
enteritis while unaffected in the total cell extract. (C) Densitometric quantiﬁcation is represent
in normal cells equalized to 1. Densitometric quantitation of Na-K-ATPase α-1 expression
(D) Densitometric quantiﬁcation is represented as relative Na-K-ATPase β-1 expression in inﬂam
titation of Na-K-ATPase β-1 expression in BLM showed a signiﬁcant decrease during chronic en
affectedduring chronic intestinal inﬂammation (n=6). (F)Na-K-ATPase β-1mRNAabundance
normalized using β-actin in all conditions.intestine. Na-K-ATPase activity was reduced approximately 3 fold
in villus cells from the chronically inﬂamed intestine (6.6 ± 0.3 nmol/mg
protein·min) compared with the normal intestine (17.3 ± 1.2 nmol/mg
protein·min) (n = 3, p b 0.001). These data indicated that Na-K-
ATPase activity was diminished in villus cells during chronic intesti-
nal inﬂammation.
3.2. Na-K-ATPase α-1 and β-1 subunit protein expression
To further delineate the molecular mechanism of this decrease, the
levels of the immuno-detectable protein of Na-K-ATPase α-1 and β-1
subunits expressed in the villus cells and BLM were quantitated by
Western blot analysis. Immunoblotting of cell extract and BLM fractions
with monoclonal Na-K-ATPase α-1-antisera revealed a protein of
97 kDa (Fig. 1A), whereas the β-1-antisera recognized a 45-kDa band
(Fig. 1B). The levels ofα-1 and β-1 immunoreactive proteinswere unaf-
fected in villus cell homogenates in control compared to that from the
chronically inﬂamed ileum. However, BLM levels of α-1 and β-1 immu-
noreactive proteins were markedly diminished in villus cells during
chronic enteritis (Fig. 1A and 1B). Densitometric quantitation showed
an approximately 50% decrease (n= 3, p b 0.01) of α-1 and an approx-
imately 40% decrease in β-1 protein levels in the BLMof villus cells fromchronic enteritis. (A) Representative Na-K-ATPase α-1 Western blot from 3 independent
l membrane (BLM) during chronic enteritis while unaffected in the total cell extract.
Pase β-1 subunit protein was also markedly diminished in villus cell BLM during chronic
ed as relative Na-K-ATPase α-1 expression in inﬂamed cells compared to total expression
in the BLM showed a signiﬁcant decrease during chronic enteritis (n = 3, *p b 0.01).
ed cells compared to total expression in normal cells equalized to 1. Densitometric quan-
teritis (n = 3, *p b 0.001). (E) In villus cells, Na-K-ATPase α-1 mRNA abundance was not
was also not alteredduring chronic enteritis (n=6). The relative abundance ofmRNAwas
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and 1D). These results indicate that, down-regulation of Na-K-ATPase
activity during chronic enteritis is a result of reduced levels of α-1 and
β-1 subunit proteins on the BLM.
3.3. Na-K-ATPase α-1 and β-1 subunit mRNA abundance
To determine whether alterations in Na-K-ATPase activity and
reduced expression of α-1 and β-1 subunit proteins in the BLM ob-
served during chronic enteritis may be secondary to alterations in
the corresponding mRNAs encoding these subunits, RTQ-PCR was
carried out. There was no alteration in α-1 subunit mRNA abun-
dance in villus cells from the chronically inﬂamed intestine
(Fig. 1E). Similarly the β-1 subunit mRNA abundance was also not
statistically different from control (Fig. 1F). These results con-
ﬁrmed that reduction of α-1 and β-1 subunit proteins in the villus
cell BLM during chronic enteritis was likely the result of post-
transcriptional regulation.
3.4. Localization of Na-K-ATPase α-1 and β-1 subunits in villus cells
Intestinal villus cells are polarized epithelial cells with a well dif-
ferentiated BBM and BLM. To conﬁrm the expression pattern of Na-Fig. 2. Localization of Na-K-ATPase α-1 and β-1 immunoreactive proteins in villus cells during c
cells fromnormal rabbit intestine (B)whereas, theNa-K-ATPaseα-1 proteinwasmostly localize
(C) Na-K-ATPase β-1 was expressed along the entire length of the lateral and basal plasma me
testine. (D) Most of the immunoreactive Na-K-ATPase β-1 was present in the cytoplasm of chrK-ATPase α-1 and β-1 subunit proteins in villus cells during chronic
enteritis, confocal immunoﬂuorescence microscopy, using antibod-
ies speciﬁc for Na-K-ATPase α-1 and β-1 subunits was performed.
Na-K-ATPase α-1 and β-1 subunit proteins were shown to be dis-
tinctly present in the BLM of villus cells from normal rabbit (Fig. 2A
and 2C). In contrast, both the proteins were localized to the cyto-
plasm instead of the BLM in the villus cells from chronically inﬂamed
intestine (Fig. 2B and 2D). Thus, these confocal microscopic studies
corroborate the results obtained by the Western blot studies of the
BLM and cell extract. These data indicate that down-regulation of
Na-K-ATPase in villus cells during chronic intestinal inﬂammation
parallels a corresponding decrease of α-1 and β-1 protein expression
in the BLM. Thus, the mechanism responsible for the alteration of Na-
K-ATPase in villus cells during chronic enteritis is defective trafﬁck-
ing of Na-K-ATPase to the BLM.
3.5. Expression of ankyrin-G and spectrin during chronic enteritis
Trafﬁcking and stabilization of Na-K-ATPase to the BLM depend
on the ankyrin–spectrin based cytoskeleton. To determine whether
this may be altered during chronic enteritis, the expression pattern
of both of the proteins in total cell extract and in the BLM of villus
cells from normal and chronically inﬂamed intestine was performedhronic enteritis. (A) The Na-K-ATPase α-1 subunit protein was present in the BLM of villus
d in the cytoplasm instead of theBLM in the villus cells from chronically inﬂamed intestine.
mbrane and no staining was found on the apical membrane of villus cells from normal in-
onically inﬂamed intestinal villus cell.
Fig. 3. Ankyrin-G protein and spectrin protein and their mRNA expression in villus cells during chronic enteritis. (A) Representative ankyrin-G Western blot from 3 independen
experiments. Ankyrin-G protein was markedly diminished in villus cell BLM and cell extract during chronic enteritis. (B) Representative Western blot of spectrin from 3 independen
experiments. Spectrin protein was unaffected in villus cells during chronic enteritis and there was no expression in the BLM. (C) Relative mRNA abundance is represented as abundanc
in inﬂamed cells compared to that in normal cells equalized to 1. In villus cells, ankyrin-G mRNA abundance quantitated by RTQ-PCR was signiﬁcantly reduced during chronic intestina
inﬂammation (n=6, p b 0.001). (D) SpectrinmRNA abundancewas not statistically affected during chronic enteritis (n= 4) andwas statistically insigniﬁcant. The relative abundance o
mRNA was normalized to β-actin in all experiments.
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decrease (n= 3, p b 0.01) in the total cell as well as in the BLM of vil-
lus cells during chronic enteritis (Fig. 3A). In contrast, while spectrinFig. 4. Co-localization of Na-K-ATPase α-1 and ankyrin-G in villus cells during chronic enteritis. (A) Na-K-ATPase α-1was expressed along the entire length of the lateral and basal plasm
membranewhile little or no stainingwas found on the BBM of villus cells from normal intestine. (B) Immunoreactive ankyrin-Gwas also distinctly present in the basolateral side of villu
cells from normal rabbit. (C) Merged picture of Na-K-ATPase α-1 and ankyrin-G showed co-localization of both of the proteins. (D) Na-K-ATPase α-1 was present in the cytoplasm o
chronically inﬂamed intestinal villus cells (E). In contrast, ankyrin was localized along the apical side instead of the BLM in the villus cells from chronically inﬂamed intestine (F). Merged
picture of Na-K-ATPase α-1 and ankyrin-G showed that both the proteins were localized to different regions of villus cells during chronic enteritis.t
t
e
l
fexpression was not altered in the total cell extract during chronic
enteritis, spectrin was nearly absent during chronic enteritis in the
villus cell BLM (Fig. 3B).a
s
f
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To determine the mechanism of alteration of ankyrin in villus cells
during chronic enteritis RTQ-PCR analysis was done. The relative abun-
dance of ankyrin was signiﬁcantly reduced (n = 6, p b 0.001) in the
villus cells from chronically inﬂamed intestine (Fig. 3C). In contrast,
there was no signiﬁcant alteration in the relative abundance of spectrin,
the other cytoskeleton partner of Na-K-ATPase (Fig. 3D). These results
indicate that the transcriptional inhibition of linker protein ankyrin
might be responsible for the altered trafﬁcking of Na-K-ATPase α-1 to
the BLM.3.7. Co-immunolocalization of Na-K-ATPase α-1 and ankyrin-G
Alterations in Na-K-ATPase α-1 and ankyrin co-localizations during
chronic enteritis was determined using immunoﬂuorescencemicrosco-
py of villus cells. Na-K-ATPase α-1 stained with Alexa Fluor® 647 anti-
body showed a strong signal along the entire length of the BLM and
little or no stainingwas found on the BBM of villus cells from normal in-
testine (Fig. 4A). Staining of same cell with Alexa Fluor® 488 antibody
for ankyrin showed it's presence at the BLM (Fig. 4B). The merged pic-
ture of Alexa Fluor® 647 and Alexa Fluor® 488 showed a distinct over-
lap in the distribution of Na-K-ATPase α-1 and ankyrin (Fig. 4C). In
contrast, Na-K-ATPase α-1 wasmostly present in the cytoplasm instead
of BLM in the villus cells from chronically inﬂamed rabbit intestine
(Fig. 4D). More surprisingly, staining with Alexa Fluor® 488 antibody
for ankyrin showed strong staining at the BBM and little or no staining
on the BLM (Fig. 4E). The merged picture of Alexa Fluor® 647 and
Alexa Fluor® 488 shows that α-1 and ankyrin are distributed differently
in villus cells during chronic enteritis (Fig. 4F). These results indicate
that depolarization of α-1 and ankyrin, and transcriptional down-
regulation of ankyrin are responsible for the altered trafﬁcking of Na-
K-ATPase α-1 during chronic enteritis. Further, this is the ﬁrst report
of apical localization of ankyrin during an intestinal pathophysiological
condition.3.8. Expression of ankyrin-G in the villus BBM during chronic enteritis
To conﬁrm the immunolocalization of ankyrin to the apical side of
villus cells during chronic enteritis Western blot analysis of brush bor-
der membranes (BBMs) from normal and chronically inﬂamed intesti-
nal villus cells was performed. Immunoreactive ankyrin-G was present
only in the BBM of chronically inﬂamed intestinal villus cells while
there was no expression in the BBM of normal rabbit villus cells (Fig. 5).Fig. 5. Expression of ankyrin-G in the BBM during chronic enteritis. Representative anky-
rin-GWestern blot showed the presence of ankyrin in the BBMof chronically inﬂamed vil-
lus cells but not in the normal villus cell BBM (n= 3, p b 0.001).3.9. Interaction of Na-K-ATPase α-1 and ankyrin-G during chronic enteritis
To determine the interaction betweenNa-K-ATPase α-1 and ankyrin
co-IP using monoclonal Na-K-ATPase α-1 antibody was performed in
normal and chronically inﬂamed intestinal villus cells followed by
Western blot analysis. The results showed reduced expression of anky-
rin in chronically inﬂamed intestinal villus cells whereas no change was
seen in Na-K-ATPase α-1 expression corroborating the previous
ﬁndings (Fig. 6), which indicates that interaction between Na-K-
ATPase α-1 and ankyrin was diminished in villus cells during chronic
enteritis.
3.10. Na-K-ATPase activity in ankyrin knockdown IEC-18 cells
All the data from the in-vivomodel of chronic intestinal inﬂamma-
tion indicate that the activity of Na-K-ATPase is decreased due to the
transcriptional down-regulation and depolarization of ankyrin which
affect trafﬁcking of Na-K-ATPase α-1 to the BLM. To determine in vitro
whether the activity of Na-K-ATPase was indeed altered secondary to
ankyrin, the enzyme activity in ankyrin knockdown IEC-18 cells was
measured. There was about a 60% decrease in the BLM localized Na-K-
ATPase (n = 3, p b 0.005) after ankyrin knockdown (Fig. 7A). Also,
ankyrin expression level was lower in knockdown cells in comparison
to non-speciﬁc siRNA transfected IEC-18 (Fig. 7B) cells. These in vitro
studies directly demonstrated that ankyrin is critical in the regulation
of Na-K-ATPase activity during chronic enteritis.
4. Discussion
This study demonstrated that in the chronically inﬂamed rabbit
small intestinal villus cells Na-K-ATPase is decreased. The relative
mRNA abundance and protein expression of α-1 and β-1 subunits
were not altered in villus cells during chronic intestinal inﬂammation.
The mechanism of reduction in BLM Na-K-ATPase activity was second-
ary to diminished BLM localization of α-1 and β-1 subunits. The
abhorrent trafﬁcking of the Na-K-ATPase α-1 subunit was a result of
transcriptional down-regulation and depolarization of ankyrin-G
protein. In fact, a similar decrease in BLM localizedNa-K-ATPasewas ob-
served in ankyrin siRNA transfected IEC-18 cells. Therefore, yet to be de-
termined immune-inﬂammatory mediator(s) inhibits the synthesis of
ankyrin-G, which in turn as a key mediator of Na-K-ATPase trafﬁcking
to the BLM reduces the activity of this enzyme during chronic intestinal
inﬂammation.
Na-K-ATPase is a ubiquitous enzyme and is responsible for the ATP-
driven 3 Na+ for 2 K+ transmembrane exchange to maintain the trans-
cellular Na+ gradient which is essential to facilitate a variety of Na-
solute co-transport processes on the BBM of intestinal epithelial
cells [4,5]. While there is a growing body of information pertainingFig. 6. Interaction of Na-K-ATPase α-1 and ankyrin-G during chronic enteritis. Ankyrin-G
expression was signiﬁcantly decreased in the co-immunoprecipitated Na-K-ATPase α-1
protein in villus cells from chronically inﬂamed intestine (n = 3, p b 0.05). Expression
of Na-K-ATPase-α-1 was unaffected.
Fig. 7. Na-K-ATPase activity in ankyrin knockdown IEC-18 cells: (A) A signiﬁcant 3 fold decrease of Na-K-ATPase activity was seen in the ankyrin siRNA transfected IEC-18 cells in com-
parison to scrambled siRNA transfected cells (n = 3, p b 0.005). (B) Representative Western blot showed that ankyrin expression was signiﬁcantly reduced in the ankyrin siRNA
transfected IEC-18 cells but not in non-speciﬁc siRNA transfected cells.
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in a variety of tissues and cell types [34–36], few studies have exam-
ined the regulation of Na-K-ATPase in the small intestine. In acute di-
arrheal diseases where there is serious ﬂuid and electrolyte loss and
decrease of coupled NaCl absorption, Na-K-ATPase dependent Na-
nutrient pathways appear to be preserved [15,37,38]. Cholera is
such a condition in which Na:H exchange, responsible for coupled
NaCl absorption mediated by Na:H and Cl:HCO3 exchange on the
BBM, is decreased [38,39]. But Na-glucose and possibly Na-amino
acid co-transport that are secondarily active and thus dependent
on the transcellular Na gradient generated by Na-K-ATPase, are pre-
served [39]. Indeed, this is the physiologic basis for oral rehydration
therapy for severe diarrheal conditions such as cholera. Oral rehy-
dration therapy is the most efﬁcacious and cost effective therapy
for diarrheal diseases in infants in the developing parts of the
world where this preventable condition nevertheless results in
more than a million deaths a year [2,3].
In the Western hemisphere, inﬂammatory bowel diseases (Crohn's
disease and ulcerative colitis) afﬂict more than a million people and
the most common clinical concern in patients with these chronic
diarrheal diseases is malabsorption of electrolytes and nutrients
resulting in malnutrition [40,41]. Na-K-ATPase activity has shown to
bedecreased duringhuman IBD andulcerative colitis [26–30]. These ob-
servations have implications for Na and solute absorption at the cellular
level in the intestine. Indeed, in a rabbit model of chronic intestinal in-
ﬂammation resembling IBD, it has been demonstrated that Na-glucose
(SGLT1), Na-amino acid (-alanine (ATB0), -glutamine (B0AT1)), Na-
bile acid (ASBT) andNa-adenosine co-transport are reduced in the villus
cells [4–7]. At least part of this decrease is secondary to the diminished
Na-extruding capacity of these cells as evidenced by the down-
regulation of Na-K-ATPase. However, the molecular mechanisms of
down-regulation of Na-K-ATPase in villus cells during chronic intestinal
inﬂammation were previously not well understood. The present study
provides new insights into the regulation of villus cell Na-K-ATPase
during chronic intestinal inﬂammation.
In a rat model of acute intestinal inﬂammation induced by 2,4,6-
trinitrobenzenesulfonic acid it was reported that there was decrease
of Na-K-ATPase activity in total enterocytes [42]. But, in normalintestine approximately 80% of the enterocytes are absorptive villus
cells while the remainder is the secretory crypt cells. Further, villus
cells almost exclusively possess Na-K-ATPase driven Na-solute co-
transport processes as compared to primarily secretory crypt cells
in the small intestine [39]. During acute inﬂammation there is villus
atrophy and crypt hypertrophy and thus, measuring Na-K-ATPase
activity in a mixture of enterocytes, as was done in this study, will
not provide mechanistic information. Nevertheless, in TNBS-
induced ileitis it was reported that there was a decrease in the
expression of α-1 and β-1 subunits in enterocytes in toto [42]. How-
ever, in the current study, during chronic intestinal inﬂammation, in
absorptive villus cells there was no alteration in the relative abun-
dance of α-1 and β-1 mRNA levels (Fig. 1). Further, α-1 and β-1 pro-
tein expression pattern in whole cell extract corroborates the results
obtained by RTQ PCR analysis (Fig. 1). Species differences, chronic
versus acute inﬂammation, and villus versus a mixture of enterocytes
may account for these differences.
Despite the absence of change in the steady state levels of α-1 and
β-1 mRNA and protein in villus cells in the chronically inﬂamed intes-
tine, current study showed that α-1 and β-1 protein concentrations
were signiﬁcantly reduced in the BLM of villus cells from chronic in-
ﬂamed intestine (Fig. 1). Indeed, when immunocytochemical studies
were performed in order to localize the subunit proteins in the villus
cells from inﬂamed intestine, α-1 and β-1 subunit proteins were dis-
tinctly absent at BLM, but were seen disseminated in the cytoplasm
(Fig. 2). These results indicate that down-regulation of Na-K-ATPase
activity during chronic enteritis was paralleled by corresponding
decreases of α-1 and β-1 subunit protein levels in the BLM, likely due
to altered intracellular trafﬁcking.
A study in renal tubule cells (MDCK) has suggested that ankyrin has
an important role in facilitating the intracellular trafﬁcking of Na-K-
ATPase in addition to stabilizing the Na-K-ATPase membrane scaffold
[36]. In the present study, for the ﬁrst time, the correlation of the
functional activity of Na-K-ATPase with ankyrin-G in the mammalian
intestinal villus cells has been reported. There was a signiﬁcant down-
regulation of ankyrin-G protein expression and mRNA abundance in
villus cells from chronically inﬂamed intestine (Fig. 3). Immunostaining
of the α-1 subunit and ankyrin showed that both the proteins were co-
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chronically inﬂamed intestine, α-1 was present in the cytoplasm in a
scattered fashion and ankyrin mostly localized towards the BBM
(Fig. 4). To conﬁrm that the depolarization of ankyrin during chronic
enteritis is a unique phenomenon, Western blot analysis using villus
BBM from normal and chronically inﬂamed rabbits was done. This also
showed the presence of ankyrin in villus cell BBM from the chronically
inﬂamed intestine but not in villus cell BBM from the normal intestine
(Fig. 5). These data suggested that the separation of the two co-
localized proteins during chronic enteritis might be the result of the
loss of interaction between ankyrin and the ankyrin binding sequence
of the α1 subunit of Na-K-ATPase. To assess this interaction IP using
Na-K-ATPase α-1 monoclonal antibody was performed followed by
Western blot analysis. The results showed the presence of a lesser
amount of ankyrin interaction during chronic enteritis (Fig. 6). The
loss of interaction was probably the result of the unavailability of anky-
rin due to transcriptional down-regulation and/or depolarization. These
ﬁndings were conﬁrmed by ankyrin knockdown in IEC-18 cells where
Na-K-ATPase was decreased (Fig. 7). Further studies are required to un-
derstand the intracellular mechanism that may be responsible for the
down-regulation of ankyrin during intestinal inﬂammation. A recent
publication has shown that an increase in miR-342-5p down-regulates
the expression of ankyrin-G [43]. Also, dinucleotide deletion in the an-
kyrin promoter and mutation in its intronic sequence have been
shown to decrease its expression in disease conditions [44,45].
In conclusion, the results of the current study demonstrated that
the mechanism of down-regulation of Na-K-ATPase in the villus cells
during chronic intestinal inﬂammation is secondary to diminished
enzyme levels at the BLM. This defective localization of Na-K-
ATPase to the BLM is a result of decreased production of and depolar-
ization of ankyrin protein in villus cells from the chronically inﬂamed
intestine. Understanding the molecular mechanisms of alterations of
Na-K-ATPase in the intestine, especially diarrheal diseases as done in
this study, is important since at the intact cell level alterations in the
BLM Na-K-ATPase contribute, at least partially, to the changes in the
absorption of Na and nutrients. Thus, regulation of Na-K-ATPase pro-
vides another option in designing treatments. Restoring the polari-
zation/localization of Na-K-ATPase in these conditions may, again,
at least partially, restore all altered Na-solute co-transport processes
in the inﬂamed intestine.
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